# Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.

> **NCT07401433** · NA · COMPLETED · sponsor: **Hayat Abad Medical Complex, Peshawar** · enrollment: 260 (actual)

## Conditions studied

- Neonatal Seizures

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Phenobarbital Sodium Injection

## Key facts

- **NCT ID:** NCT07401433
- **Lead sponsor:** Hayat Abad Medical Complex, Peshawar
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-08
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-04-10
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2026-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07401433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07401433, "Levetiracetam Versus Phenobarbitone for the Treatment of Neonatal Seizures in a Tertiary Care Hospital.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07401433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*